Bearish flow noted in Centene (CNC) with 3,182 puts trading, or 3x expected. Most active are Feb-25 57.5 puts and Mar-25 52.5 puts, with total volume in those strikes near 2,900 contracts.

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Centene (CNC – Research Report), with a price target of $93.00. The company’s shares closed yesterday at $61.29.

On Tuesday, Centene touted healthy membership growth in Affordable Care Act plans, while arguing that Medicaid and Medicare — businesses that proved rocky last year — will stabilize in 2025.

Shares of Centene (NYSE:CNC) slipped 4% Tuesday after the healthcare plan provider, which specializes in Medicaid services, issued its Q4 earnings report and 2025 forecast. For Q4, Centene (NYSE ...

Scott Fidel; Analyst; Stephens Inc. Good day, and welcome to the Centene Corporation fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) Please note today's event ...

Feb 4 (Reuters) - Centene's (CNC.N), opens new tab shares fell nearly 5% on Tuesday hurt by elevated costs tied to its government-backed Medicaid plans, overshadowing a better-than-expected ...

Centene Corp. the Clayton-based managed health care giant, has hired the first president for a new business unit. Centene Corp. the Clayton-based managed health care giant, has hired the first ...

CEO Sarah London highlighted Centene's strategic direction heading into 2025, emphasizing strong operational improvements and the deployment of artificial intelligence to modernize administrative ...